MedTrace Logo

Surgical Intervention and Lymphatic Diseases.

NCT06067880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2023-10-05

No results posted yet for this study

Summary

Supermicrosurgical LVA has been proven effective in treating moderate to severe lymphedema, including cases with diffuse dermal backflow (DB) and even severe lymphatic fluid leakage. Therefore, the use of LVA should not be limited to mild lymphedema, and its indications should be expanded to become a primary surgical approach for more severe lymphedema cases. Among all surgical procedures for lymphedema, LVA is the least invasive, allowing for rapid recovery, minimizing the complications, and reducing medical costs.

Conditions

  • Lymphedema

Interventions

OTHER

Cancer-related Unilateral

This group included patients who have used only contraction type LVs.

OTHER

Normal + Ectasis LVs

This group included patients who had only non- contraction type LVs.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-23
Primary Completion
2023-03-10
Completion
2023-09-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06067880 on ClinicalTrials.gov